Premature Ejaculation Treatment: Creams, Pills, Injections and What Actually Works

Premature ejaculation (PE) is the most prevalent male sexual complaint worldwide, affecting roughly 20–30% of men across all age groups. Yet, unlike erectile dysfunction, most men do not seek help — partly through embarrassment, partly because they underestimate how treatable it is.

This guide, written by a practising andrologist in Istanbul, walks through every evidence-based PE treatment on the market in 2026 — including options approved in Europe and Turkey but not in the United States. It uses the classifications and recommendations of the International Society for Sexual Medicine (ISSM), the American Urological Association (AUA/SMSNA) and the European Association of Urology (EAU).

Defining PE — lifelong vs acquired

The ISSM criteria (2014, still current) split PE into two clinical entities:

An office-based option worth mentioning is glans (penis head) filler for premature ejaculation.

• Lifelong PE — ejaculation always or nearly always within about 1 minute of vaginal penetration, from the first sexual experiences onwards. Neurobiological, with a strong genetic and serotonin-receptor component.
• Acquired PE — a clinically meaningful reduction in latency time (often to about 3 minutes or less) after previously normal function. Often driven by acquired ED, hyperthyroidism, prostatitis or psychological factors.

Two additional descriptors — variable PE (natural fluctuation) and subjective PE (normal IELT but distressing) — are considered normal variants, not disorders, and rarely require pharmacological treatment.

Treatment strategy differs by subtype. Lifelong PE almost always requires ongoing pharmacological therapy because the neurobiology does not change; acquired PE can often be resolved by treating the underlying trigger.

The treatment ladder

Both AUA and EAU guidelines endorse a stepwise approach:

A nerve-targeted alternative when medication fails is selective dorsal cryoablation for premature ejaculation.

1. Patient and partner counselling; address unrealistic expectations
2. Behavioural techniques and pelvic-floor training
3. Topical anaesthetics
4. On-demand dapoxetine (where available)
5. Off-label daily SSRI
6. Combined pharmacological plus topical therapy
7. Consider tramadol, PDE5 inhibitors (if co-morbid ED) or specialist referral
8. Investigational surgical options only in refractory lifelong PE

Behavioural therapy and pelvic floor training

Start-stop and squeeze techniques roughly double IELT at 8 weeks. Pelvic-floor rehabilitation (Pastore et al., 2014) increases mean IELT from about 32 seconds to 146 seconds in men with lifelong PE. These non-pharmacological approaches should be offered to every patient.

Behavioural work alone is often insufficient for lifelong PE with baseline IELT well under one minute — but it enhances the results of medication and lowers relapse when medication is later reduced. Read the full behavioural protocol in our companion guide on how to last longer in bed.

Topical anaesthetics (lidocaine, prilocaine, EMLA)

Topical anaesthetics reduce glans sensitivity just enough to raise the ejaculation threshold. A 2016 meta-analysis (Pu et al.) reported IELT increases of roughly 3–8× with excellent tolerability.

A non-drug option that some men trial first is low-intensity shockwave therapy for ED.

Available forms include:

• Metered lidocaine 10% spray (e.g. Fortacin / Priligy Spray in the EU): 3 sprays to the glans, 5 minutes before intercourse.
• EMLA cream (2.5% lidocaine + 2.5% prilocaine): 20–30 minute onset; can cause more numbness.
• Single-use lidocaine wipes: convenient and dose-consistent.

Practical caveats: apply, wait 10–15 minutes, then wipe off excess; use a condom to prevent transfer to the partner (partner numbness is the commonest reason for discontinuation); avoid benzocaine-containing products because of methaemoglobinaemia risk.

Dapoxetine (Priligy) — on-demand SSRI

Dapoxetine is a short-acting selective serotonin reuptake inhibitor developed specifically for PE. It is licensed in the EU, UK, Turkey, and most of Asia and Latin America. It is not FDA-approved in the United States.

Anatomical length or girth is a separate procedure — details on our penis enlargement surgery page.

How it is taken: 30 mg or 60 mg tablet 1–3 hours before anticipated intercourse, at most once every 24 hours. Peak effect at 1–2 hours; short half-life so cleared by the next day.

Efficacy: pivotal trials (Pryor et al., Lancet 2006; McMahon et al.) showed a 2.5–3× IELT increase versus placebo. Best for men who want on-demand use without daily medication.

Side effects: nausea (~11%), dizziness (~6%), headache (~6%), rare orthostatic (dizziness on standing) events. Avoid alcohol and do not combine with other SSRIs, MAO inhibitors or thioridazine. Cannot be used with tramadol or St John’s wort.

Off-label daily SSRIs

Daily SSRIs remain the largest-effect pharmacological option. All are off-label for PE:

Waldinger’s meta-analyses consistently place paroxetine at the top for raw IELT gain. Trade-off: side-effect burden (reduced libido, fatigue, weight change, ED, delayed orgasm) is higher with daily SSRIs, and abrupt discontinuation must be avoided because of withdrawal syndrome. Rare but serious concerns include emotional blunting and — with paroxetine specifically — possible post-SSRI sexual dysfunction (PSSD).

Daily SSRI treatment is therefore best when dapoxetine has failed, when the man wants sex more than 2–3 times per week, or when co-existing anxiety or depression makes an SSRI dually appropriate.

Tramadol — a limited-use option

Tramadol is a weak opioid with serotonergic activity. On-demand doses of 25–100 mg roughly 4–6 hours before intercourse extend IELT 2–3× (Bar-Or et al., Wu et al.). It is sometimes considered when dapoxetine and daily SSRIs are ineffective or contraindicated.

Foundational primer: premature ejaculation causes and treatment.

The problem: tramadol carries dependence risk, potentiates serotonin syndrome when combined with SSRIs, causes nausea and dizziness, and is a controlled substance in most jurisdictions. Guidelines including the ISSM recommend tramadol only as a limited third- or fourth-line option under specialist supervision, ideally in men with lifelong PE unresponsive to first-line therapy.

PDE5 inhibitors when PE co-exists with ED

Roughly one in three men with PE also has some degree of erectile dysfunction. In this “PE with comorbid ED” phenotype, PDE5 inhibitors (sildenafil, tadalafil) improve both the erection and — indirectly — ejaculatory latency, because performance anxiety collapses when the erection is reliable.

Guidelines do not recommend PDE5 inhibitors as monotherapy for isolated PE without ED. When both conditions co-exist, treating the ED first is often enough to normalise ejaculatory control.

Combined therapy — the highest-effect protocol

Trials directly comparing monotherapy with combined regimens consistently favour combination. A representative protocol used in our Istanbul practice:

Curvature (Peyronie’s) has its own ladder — see Peyronie’s disease treatment.

• Dapoxetine 30–60 mg on demand or daily SSRI (paroxetine / sertraline)
• Plus topical lidocaine spray 5–15 minutes before intercourse
• Plus structured behavioural coaching (start-stop, squeeze, pelvic floor training)
• Plus partner-inclusive counselling to reduce performance anxiety

Combined therapy typically achieves IELT increases in the 6–10× range and — critically — the highest patient-reported satisfaction and lowest treatment dropout.

Hyaluronic acid glans injections

Hyaluronic acid injected into the glans penis has been proposed as a means to reduce sensitivity by expanding the connective-tissue layer above the sensory nerves. Small studies (Kwak et al.) report modest IELT gains lasting 6–12 months.

If a diagnosis is missing, start with the 12 medical causes of erectile dysfunction.

Concerns include product migration, nodule formation, uneven texture, transient hypoaesthesia and — because the studies are small and mostly single-centre — limited high-quality evidence. Neither the ISSM, EAU nor AUA guidelines currently endorse glans HA injection as standard PE therapy. Consider only in men who have failed all pharmacological options and have been fully counselled about the evidence gap.

Selective dorsal neurectomy — a controversial surgery

Selective dorsal nerve neurotomy (SDN) partially divides the dorsal penile nerve branches to reduce glans sensitivity. Popularised in Korea and China, published series report substantial IELT increases in the 3–5× range.

Concerns:

• Risk of permanent glans numbness
• Risk of anorgasmia
• Risk of ED if branches supplying the erectile mechanism are damaged
• Irreversibility
• No high-quality randomised trials outside East Asia

Neither AUA nor EAU guidelines endorse SDN as standard treatment. Where I practise, I do not recommend it outside a very small subgroup of well-counselled men with severe, refractory lifelong PE who have failed every pharmacological and behavioural option.

Effectiveness comparison table

Which treatment is truly permanent?

Honest answer: no treatment for lifelong PE is truly permanent in the sense that a course of six months resets the neurobiology forever. The underlying serotonin-receptor sensitivity that drives lifelong PE is genetic. Discontinuing an SSRI or dapoxetine typically returns IELT toward baseline within weeks.

Not every man can safely take PDE5 tablets — see Viagra side effects and who should never take it.

What can produce long-lasting change:

• Behavioural techniques and pelvic-floor training — the skills persist as long as the muscles are maintained.
• Combined therapy taken long-term at the lowest effective dose.
• Treatment of underlying causes in acquired PE (treating prostatitis, hyperthyroidism, comorbid ED) — often fully resolves the PE.
• Reduced performance anxiety after months of reliable success on medication.

For most men with lifelong PE the pragmatic goal is sustained good control, not “cure.”

Doctor’s perspective — Op. Dr. Cem İpek

The single treatment decision that changes outcomes most is honestly diagnosing whether PE is lifelong or acquired. Acquired PE with a clear trigger — a new relationship, new anxiety, a change in erectile firmness — usually resolves when we treat that trigger. Lifelong PE requires ongoing pharmacological support and that is not a failure; it is the same logic as taking an antihypertensive.

I prescribe dapoxetine to most patients as the first-line pharmacological option because the on-demand model fits real life better than daily dosing. When dapoxetine is not enough — often in severe lifelong PE — I switch to a daily SSRI, usually sertraline or escitalopram before paroxetine, because their side-effect profile is easier to live with long term.

I discourage patients from pursuing surgical options like dorsal nerve neurectomy or hyaluronic acid glans injection outside a specialist tertiary setting. The evidence base is thin, complications can be irreversible, and 95% of men achieve good control with the combination of a topical spray, an SSRI, and structured behavioural coaching.

When to see a urologist

Book a consultation if:

• Your IELT is consistently under one minute or under a threshold that causes personal or partner distress
• You want a proper diagnostic distinction between lifelong and acquired PE
• You have comorbid erection difficulty
• Behavioural techniques have not helped after 8–12 weeks
• You are currently self-medicating with tramadol, undeclared “natural” capsules, or online SSRIs
• You have pain on ejaculation, blood in semen, or urinary symptoms suggesting prostatitis
• You want to try dapoxetine or an SSRI safely with proper drug-interaction screening

Frequently asked questions